Publicaciones en las que colabora con MARÍA DEL CARMEN MARTÍNEZ MORA (48)

2015

  1. Th17 polarization of memory Th cells in early arthritis: The vasoactive intestinal peptide effect

    Journal of Leukocyte Biology, Vol. 98, Núm. 2, pp. 257-269

2014

  1. Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis

    PLoS ONE, Vol. 9, Núm. 1

  2. Vasoactive Intestinal Peptide Maintains the Nonpathogenic Profile of Human Th17-Polarized Cells

    Journal of Molecular Neuroscience, Vol. 54, Núm. 3, pp. 512-525

2012

  1. Effect of VIP on the balance between cytokines and master regulators of activated helper T cells

    Immunology and Cell Biology, Vol. 90, Núm. 2, pp. 178-186

  2. VIP in inflammatory bowel disease: State of the art

    Endocrine, Metabolic and Immune Disorders - Drug Targets, Vol. 12, Núm. 4, pp. 316-322

2010

  1. New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes

    Immunology and Cell Biology, Vol. 88, Núm. 7, pp. 734-745

  2. Peptides targeting toll-like receptor signalling pathways for novel immune therapeutics

    Current Pharmaceutical Design, Vol. 16, Núm. 9, pp. 1063-1080

2008

  1. Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: Implications for rheumatoid arthritis

    Brain, Behavior, and Immunity, Vol. 22, Núm. 3, pp. 312-317

  2. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4

    Peptides, Vol. 29, Núm. 6, pp. 948-956

  3. Vasoactive intestinal peptide as a healing mediator in Crohn's disease

    NeuroImmunoModulation, Vol. 15, Núm. 1, pp. 46-53

2007

  1. Regulation of TLR expression, a new perspective for the role of VIP in immunity

    Peptides, Vol. 28, Núm. 9, pp. 1825-1832

  2. Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation

    NeuroImmunoModulation

2006

  1. Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis

    Annals of the New York Academy of Sciences

  2. PAC1 receptor: Emerging target for septic shock therapy

    Annals of the New York Academy of Sciences

  3. VIP and tolerance induction in autoimmunity

    Annals of the New York Academy of Sciences

  4. VIP decreases TLR4 expression induced by LPS and TNF-α treatment in human synovial fibroblasts

    Annals of the New York Academy of Sciences

  5. VIP-PACAP system in immunity: New insights for multitarget therapy

    Annals of the New York Academy of Sciences

2005

  1. Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock

    Journal of Leukocyte Biology, Vol. 77, Núm. 5, pp. 729-738

  2. Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.

    Arthritis research & therapy, Vol. 7, Núm. 5

  3. Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP

    Journal of Leukocyte Biology, Vol. 78, Núm. 2, pp. 491-502